BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-14.73%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$5.16B
AUM Growth
+$5.16B
(-18%)
Cap. Flow
-$29M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
40.75%
Holding
231
New
16
Increased
80
Reduced
52
Closed
17
Top Buys
| 1 |
Black Diamond Therapeutics
BDTX
|
$33.2M |
| 2 |
Fate Therapeutics
FATE
|
$32.9M |
| 3 |
Intuitive Surgical
ISRG
|
$21.8M |
| 4 |
MTEM
Molecular Templates, Inc.
MTEM
|
$21.5M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$21M |
Top Sells
| 1 |
Teladoc Health
TDOC
|
$85.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
$49.3M |
| 3 |
Moderna
MRNA
|
$29.5M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$27.6M |
| 5 |
QuidelOrtho
QDEL
|
$21.9M |
Sector Composition
| 1 | Healthcare | 95.76% |
| 2 | Technology | 0.56% |
| 3 | Industrials | 0.54% |
| 4 | Communication Services | 0.17% |
| 5 | Financials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Tandem Diabetes Care
TNDM
$845M
| $12.6M | 0.24% |
195,038
-5,109
| -3% | -$329K |
|
77
ResMed
RMD
$40.2B
| $11.6M | 0.22% |
78,505
+2,695
| +4% | +$397K |
|
|
AMED
78
DELISTED
Amedisys
AMED
| $11.2M | 0.22% |
61,143
+7,778
| +15% | +$1.43M |
|
79
Thermo Fisher Scientific
TMO
$186B
| $11.2M | 0.22% |
39,552
-25,245
| -39% | -$7.16M |
|
|
80
QuidelOrtho
QDEL
$1.95B
| $11.1M | 0.22% |
113,955
-223,573
| -66% | -$21.9M |
|
|
TRHC
81
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $10.9M | 0.21% |
208,809
+7,174
| +4% | +$375K |
|
82
iRhythm Technologies
IRTC
$5.46B
| $10.8M | 0.21% |
133,259
-3,304
| -2% | -$269K |
|
83
Gilead Sciences
GILD
$140B
| $10.8M | 0.21% |
144,500
+136,000
| +1,600% | +$10.2M |
|
|
SWAV
84
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $10.8M | 0.21% |
324,661
+113,903
| +54% | +$3.78M |
|
|
CHNG
85
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $10.8M | 0.21% |
1,077,575
+213,653
| +25% | +$2.13M |
|
86
Zimmer Biomet
ZBH
$21B
| $10.6M | 0.21% |
104,832
-110,200
| -51% | -$11.1M |
|
87
Idexx Laboratories
IDXX
$51.8B
| $10.2M | 0.2% |
41,911
-5,550
| -12% | -$1.34M |
|
88
Supernus Pharmaceuticals
SUPN
$2.53B
| $9.95M | 0.19% |
552,800
-22,800
| -4% | -$410K |
|
|
GNMK
89
DELISTED
GenMark Diagnostics, Inc
GNMK
| $9.94M | 0.19% |
2,411,926
-29,315
| -1% | -$121K |
|
90
Regeneron Pharmaceuticals
REGN
$61.5B
| $9.33M | 0.18% |
19,100
-2,900
| -13% | -$1.42M |
|
91
Integra LifeSciences
IART
$1.18B
| $8.82M | 0.17% |
197,420
-60,352
| -23% | -$2.7M |
|
92
Inspire Medical Systems
INSP
$2.77B
| $8.27M | 0.16% |
137,225
-125,992
| -48% | -$7.59M |
|
93
Quanterix
QTRX
$211M
| $8.19M | 0.16% |
445,673
+10,456
| +2% | +$192K |
|
|
NVRO
94
DELISTED
NEVRO CORP.
NVRO
| $7.99M | 0.15% |
79,906
-29,799
| -27% | -$2.98M |
|
95
Veeva Systems
VEEV
$44B
| $7.96M | 0.15% |
50,884
| – | – |
|
|
GTHX
96
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $7.96M | 0.15% |
721,925
| – | – |
|
97
Zai Lab
ZLAB
$3.68B
| $7.93M | 0.15% |
154,000
+33,218
| +28% | +$1.71M |
|
|
LVGO
98
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $7.74M | 0.15% |
271,232
+88,658
| +49% | +$2.53M |
|
99
Phreesia
PHR
$1.88B
| $7.59M | 0.15% |
360,998
+89,953
| +33% | +$1.89M |
|
|
VCRA
100
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $7.45M | 0.14% |
350,724
+46,581
| +15% | +$989K |
|